Sex differences in motor behavior in the MPTP mouse model of Parkinson's disease

被引:62
作者
Antzoulatos, Eleni [1 ,2 ]
Jakowec, Michael W. [3 ,4 ]
Petzinger, Giselle M. [3 ,4 ]
Wood, Ruth I. [1 ]
机构
[1] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA
[2] Univ So Calif, Neurosci Grad Program, Los Angeles, CA 90033 USA
[3] Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90033 USA
[4] Univ So Calif, Dept Biokinesiol, Los Angeles, CA 90033 USA
关键词
Parkinson's disease; Striatum; Substantia nigra; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Motor behavior; Sex characteristics testosterone; Estrogen; GENDER-DIFFERENCES; SUBSTANTIA-NIGRA; ANIMAL-MODELS; TIME-COURSE; MICE; ESTROGEN; RATS; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; 6-HYDROXYDOPAMINE; NEUROPROTECTION;
D O I
10.1016/j.pbb.2010.03.009
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Sex differences in Parkinson's disease (PD) have been reported in humans and rodent models, with a higher incidence in men and increased severity in male rodents. The current study examined sex differences and the effects of gonadal steroid hormones in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned mouse model of PD. Male (n = 51) and female (n = 50) mice were gonadectomized and received physiologic replacement with testosterone or estrogen (Experiment 1), or no hormones (Experiment 2). Two weeks later, mice received either MPTP (10 mg/kg per day for 5 days) or saline. Higher doses killed female mice. Mice were tested one week after MPTP for motor performance using rotarod, pole and gait tests. In hormone-treated mice, males significantly outperformed females in all three tests (p<0.05). Compared with females, males had a greater overall rotarod performance (ORP: 1317.1 +/- 98.3 vs. 988.1 +/- 95.6), descended a pole faster (7.1 +/- 0.6 vs. 9.6 +/- 0.7 s), and had longer stride lengths (hindlimb 7.3 +/- 0.1 vs. 6.8 +/- 0.1 cm). By contrast, ovariectomized female mice receiving saline outperformed castrated males on the rotarod (1296.6 +/- 83.3 vs. 811.2 +/- 113.7, p<0.05) and descended a pole faster (9.7 +/- 2.0 vs. 15.6 +/- 1.9s, p<0.05). MPTP significantly impaired ORP (p<0.05) in hormone-treated males (703.7 +/- 65.5) and females (432.8 +/- 88.6, p<0.05). After MPTP, stride length was selectively decreased in males (hindlimb 6.6 +/- 0.1 cm, p<0.05), and pole test performance was unimpaired in either sex. After gonadectomy, MPTP did not decrease motor performance in males (p>0.05) but significantly reduced ORP in females (975.9 +/- 110.3 vs. saline females, p<0.05). Our results show that small, chronic doses of MPTP produce subtle, sexually-dimorphic impairments in motor performance, but without a loss of tyrosine hydroxylase-positive neurons in the substantia nigra. In gonadectomized mice, this sex difference is reversed. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:466 / 472
页数:7
相关论文
共 52 条
[31]   Parkinson's disease [J].
Lees, Andrew J. ;
Hardy, John ;
Revesz, Tamas .
LANCET, 2009, 373 (9680) :2055-2066
[32]  
Lyons KE, 1998, CLIN NEUROPHARMACOL, V21, P118
[33]   Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion [J].
Matsuura, K ;
Kabuto, H ;
Makino, H ;
Ogawa, N .
JOURNAL OF NEUROSCIENCE METHODS, 1997, 73 (01) :45-48
[34]   The impact of gender and estrogen on striatal dopaminergic neurotoxicity [J].
Miller, DB ;
Ali, SF ;
O'Callaghan, JP ;
Laws, SC .
NEUROCHEMISTRY OF DRUGS OF ABUSE: COCAINE, IBOGAINE, AND SUBSTITUTED AMPHETAMINES, 1998, 844 :153-165
[35]   Enhanced neuroprotective effect by combination of bromocriptine and Hypericum perforatum extract against MPTP-induced neurotoxicity in mice [J].
Mohanasundari, M. ;
Srinivasan, M. S. ;
Sethupathy, S. ;
Sabesan, M. .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2006, 249 (02) :140-144
[36]   Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: Differential actions of estrogen in males and females [J].
Murray, HE ;
Pillai, AV ;
McArthur, SR ;
Razvi, N ;
Datla, KP ;
Dexter, DT ;
Gillies, GE .
NEUROSCIENCE, 2003, 116 (01) :213-222
[37]  
OGAWA N, 1985, RES COMMUN CHEM PATH, V50, P435
[38]   GAIT TOPOGRAPHY IN RAT LOCOMOTION [J].
PARKER, AJ ;
CLARKE, KA .
PHYSIOLOGY & BEHAVIOR, 1990, 48 (01) :41-47
[39]   Mouse model of Parkinsonism: A comparison between subacute MPTP and chronic MPTP/probenecid treatment [J].
Petroske, E ;
Meredith, GE ;
Callen, S ;
Totterdell, S ;
Lau, YS .
NEUROSCIENCE, 2001, 106 (03) :589-601
[40]   Effects of treadmill exercise on dopaminergic transmission in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury [J].
Petzinger, Giselle M. ;
Walsh, John P. ;
Akopian, Garnik ;
Hogg, Elizabeth ;
Abernathy, Avery ;
Arevalo, Pablo ;
Turnquist, Patty ;
Vuckovic, Marta ;
Fisher, Beth E. ;
Togasaki, Daniel M. ;
Jakowec, Michael W. .
JOURNAL OF NEUROSCIENCE, 2007, 27 (20) :5291-5300